ArticleFrontiers in oncology2021

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer.

Maria Gabriela O Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.